Company Filing History:
Years Active: 2010
Title: Hee-Gu Lee: Innovator in Monoclonal Antibody Research
Introduction
Hee-Gu Lee is a renowned inventor based in Daejeon, South Korea. He is credited with significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies.
Latest Patents
Hee-Gu Lee holds one patent focused on IL-32 monoclonal antibodies and their applications. The patent details the creation of monoclonal antibodies that are specific for interleukin-32 (IL-32), previously referred to as 'natural killer cell transcript 4' or 'NK4'. Additionally, the invention includes hybridomas that secrete these specific monoclonal antibodies. It also provides diagnostic methods and kits, such as ELISA and Western blot, which utilize these antibodies for various applications.
Career Highlights
Hee-Gu Lee works at the Konkuk University Industrial Cooperation Corporation, where he engages in research and development efforts that bridge academic advancements with industrial applications. His work significantly contributes to the understanding and diagnostic capabilities related to IL-32.
Collaborations
Throughout his career, Hee-Gu Lee has collaborated with several notable coworkers, including Ki-Hong Kim and Jung-Hyun Shim. These partnerships enhance the innovation and application of his research, facilitating further advancements in the study of monoclonal antibodies.
Conclusion
Hee-Gu Lee exemplifies the spirit of innovation in the biotechnology sector, with his patent on IL-32 monoclonal antibodies paving the way for improved diagnostic methods. His work at the Konkuk University Industrial Cooperation Corporation, along with the collaborative efforts with peers, continues to impact the scientific community positively.